Gyeonggi-do, South Korea

Kyung Hoi Cha

This inventor holds 4 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignees: Dong Kook Pharm Co., Ltd, Dongkook Pharmaceutical Co., Ltd.. Active years: 2013-2019.

USPTO Granted Patents = 4 

% Patents Active = 75.0

 

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Yongin, KR (2014)
  • Gyeonggi-Do, KR (2013 - 2019)

Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kyung Hoi Cha: Innovator in Pharmaceutical Advancements

Introduction

Kyung Hoi Cha is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 4 patents to his name, Cha's work has the potential to enhance patient care and treatment efficacy.

Latest Patents

Cha's latest patents include a novel strain with improved daptomycin productivity and a method for producing daptomycin using this strain. Additionally, he has developed a pharmaceutical composition for parenteral administration containing donepezil. This composition is designed for sustained release, allowing for continuous in vivo release for 2-12 weeks or more. This innovation aims to reduce the frequency of administration for patients while maintaining effective blood concentration over an extended period.

Career Highlights

Throughout his career, Kyung Hoi Cha has worked with prominent companies in the pharmaceutical industry, including Dong Kook Pharm Co., Ltd and Dongkook Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and formulation.

Collaborations

Cha has collaborated with notable colleagues such as Hyuk Chul Kwon and Man Dong Rho. These partnerships have likely facilitated the advancement of his research and innovations in the pharmaceutical sector.

Conclusion

Kyung Hoi Cha's contributions to pharmaceutical innovations demonstrate his commitment to improving patient outcomes through advanced drug formulations. His work continues to influence the field and pave the way for future advancements in medication delivery systems.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…